[HTML][HTML] Current status of COVID-19 vaccine development: focusing on antigen design and clinical trials on later stages

P Lee, CU Kim, SH Seo, DJ Kim - Immune network, 2021 - ncbi.nlm.nih.gov
The global outbreak of coronavirus disease 2019 (COVID-19) is still threatening human
health, economy, and social life worldwide. As a counteraction for this devastating disease …

COVID-19 vaccines: current understanding on immunogenicity, safety, and further considerations

Q He, Q Mao, J Zhang, L Bian, F Gao, J Wang… - Frontiers in …, 2021 - frontiersin.org
The world has entered the second wave of the COVID-19 pandemic, and its intensity is
significantly higher than that of the first wave of early 2020. Many countries or regions have …

[HTML][HTML] From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era

G Miao, Z Chen, H Cao, W Wu, X Chu, H Liu… - Biomedicine & …, 2023 - Elsevier
The COVID-19 pandemic has affected millions of people and posed an unprecedented
burden on healthcare systems and economies worldwide since the outbreak of the COVID …

A review of the safety and efficacy of current COVID-19 vaccines

Z Huang, Y Su, T Zhang, N Xia - Frontiers of Medicine, 2022 - Springer
Vaccination is the most effective and feasible way to contain the Coronavirus disease 2019
(COVID-19) pandemic. The rapid development of effective COVID-19 vaccines is an …

Coronavirus disease 2019 vaccine development: an overview

R Sumirtanurdin, MI Barliana - Viral immunology, 2021 - liebertpub.com
To this day, the coronavirus disease 2019 (COVID-19) pandemic has not shown signs of
abating. Moreover, the virus responsible for the pandemic, severe acute respiratory …

Humoral and cellular immunity and the safety of COVID-19 vaccines: a summary of data published by 21 May 2021

K Xu, L Dai, GF Gao - International Immunology, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19) has caused millions of deaths, and serious
consequences to public health, economies and societies. Rapid responses in vaccine …

Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms

M Bayat, Y Asemani, S Najafi - International Immunopharmacology, 2021 - Elsevier
The calamity of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2),
COVID-19, is still a global human tragedy. To date, no specific antiviral drug or therapy has …

Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19

Q Li, J Wang, Y Tang, H Lu - Drug Discoveries & Therapeutics, 2021 - jstage.jst.go.jp
The ongoing COVID-19 pandemic, caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has become a global threat. Although non-pharmaceutical …

Immunological considerations for COVID-19 vaccine strategies

M Jeyanathan, S Afkhami, F Smaill, MS Miller… - Nature Reviews …, 2020 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to …

COVID-19 vaccines currently under preclinical and clinical studies, and associated antiviral immune response

S Jain, H Batra, P Yadav, S Chand - Vaccines, 2020 - mdpi.com
With a death toll of over one million worldwide, the COVID-19 pandemic caused by SARS-
CoV-2 has become the most devastating humanitarian catastrophe in recent decades. The …